Rivaroxaban (BAY 59-7939)

DRUG2 trials

Sponsors

Bayer

Conditions

Embolism, Atrial Fibrillation and Venous Thrombosis

Phase 1

Bioequivalence Study of Rivaroxaban in Japanese Healthy Adult Male Subjects

CompletedNCT02537405

BayerEmbolism, Atrial Fibrillation and Venous Thrombosis

Start: 2014-02-28End: 2014-04-30Updated: 2015-09-01

Bioequivalence Study of Rivaroxaban

CompletedNCT02537457

BayerEmbolism, Atrial Fibrillation and Venous Thrombosis

Start: 2014-01-31End: 2014-04-30Updated: 2015-09-01